// Company Overview //
| Stock Name | 君百延集團控股有限公司 |
| Stock Code | 08372 |
| Company Full Name | 君百延集團控股有限公司 |
| Industry | 醫療保健 |
| Principal Activities | 公司主要供應醫療儀器及提供醫療儀器解決方案。 |
| Listing Date | 2018-03-29 |
| Listing Rules Era | Old Rules |
| Listing Rules Chapter | No data |
| Weighted Voting Rights (WVR) | No |
| Registered Address (Mainland China) | 香港新界荃灣沙咀道6號嘉達環球中心29樓2901-2903室及2905室 |
| Business Address (Hong Kong) | No data |
| Place of Incorporation | 開曼群島 |
| Listing Method | 發售以供認購 + 發售以供配售 |
| Listing Board | GEM |
| Website | http://www.grandbrilliancegroup.com |
| Share Registrar | 卓佳證券登記有限公司 |
| Registrar Contact | (852)2980 1333 |
| A-Share/US Dual Listing | No data |
// Offering Information //
| Offer Price | HK$ 0.34 / shares |
| Total Funds Raised | HK$ 56,280,000 |
| Subscription Multiple | 253.4x |
// Valuation & Financials //
| Market Cap (at Offer Price) | HK$ 0 |
| Market Cap at Listing (HKEX) | HK$ 268,000,000 |
// First Day Performance
| First Day Close | Loading... |
| First Day Open | HK$ 0.415 |
| First Day Change | 19.40% |
| First Day Volume | 258040000.0 |
| First Day Turnover | 98842200.0 |
// Price Chart //
// Use of Proceeds
| Use of Proceeds | 1、約6.9百萬港元(或約20.0%)將用于追加投資,拓展服務組合及加強銷售及營銷活動,以進一步滲透醫療儀器市場及提高我們在香港醫療儀器市場的市場份額;
2、約10.7百萬港元(或約30.9%)將用于招聘兩名工程師、一名登記護士、一名物理治療師、七名產品代表、兩名營銷人員、兩名研發人員、兩名信息科技技術人員、一名倉管員、一名行政人員、一名會計人員、兩名司機及兩名物流人員,擴大勞工隊伍及支付彼等直至2020年3月31日前的薪金,以應對我們業務的擴張;
3、約8.8百萬港元(或約25.4%)將部分用于近期選擇性尋求戰略收購機會;
4、約1.3百萬港元(或約3.8%)將用于加大研發及產品開發力度;
5、約2.5百萬港元(或約7.1%)將用于升級我們的資訊科技系統;
6、約2.2百萬港元(或約6.4%)將用于擴大我們的倉庫、建立展廳及升級辦公室的功能;
7、約2.2百萬港元(或約5.5%)將用作本集團的一般營運資金。 |
// Underwriting Syndicate //
联席账簿管理人 (2)
国泰君安证券(香港)有限公司
瑞邦证券有限公司
联席牵头经办人 (2)
国泰君安证券(香港)有限公司
瑞邦证券有限公司
// Cornerstone Investors //
This stock has no cornerstone investors.
// Directors & Management //
| Chairman | 黃碧君 |
| Company Secretary | 李嘉文 |
No director data available.
// Major Shareholders //
| Major Shareholders & Holdings | 黃碧君(71.0%) |
Disclaimer & Risk Warning
Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.
Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. Some data is supplemented from HKEX New Listing Reports ([HKEX]). All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.
Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.
Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.
Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.